|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/26 | |
| A61P 9/04 |
| (11) | Patento numeris | 2525809 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11704174.9 |
| Europos patento paraiškos padavimo data | 2011-01-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-11-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-08-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/DK2011/050018 |
| Data | 2011-01-20 |
| (87) | Numeris | WO 2011/088837 |
| Data | 2011-07-28 |
| (30) | Numeris | Data | Šalis |
| 296657 P | 2010-01-20 | US |
| (72) |
PETERSEN, J rgen S berg, CH
KJOELBYE, Anne Louise, CH
SKOVGAARD, Marie, DK
PEDERSEN, Henrik Duelund, DK
AXELSEN, Lene, DK
RIBER, Ditte, DK
MEIER, Eddi, DK
HANSEN, Rie Schultz, DK
FOSGERAU, Keld, DK
LARSEN, Bjarne Due, DK
|
| (73) |
Zealand Pharma A/S,
Smedeland 36, 2600 Glostrup,
DK
|
| (54) | GLUCAGON-GLP1 DUAL AGONISTS FOR USE IN THE TREATMENT OF CARDIAC CONDITIONS |
| GLUCAGON-GLP1 DUAL AGONISTS FOR USE IN THE TREATMENT OF CARDIAC CONDITIONS |